Interview: German Diagnostics Industry Questions Wisdom Of Reducing Coronavirus Test Reimbursement
COVID-19 testing capacity remains a priority, but reimbursement issues have come back onto agenda for Germany IVD manufacturers
Executive Summary
German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.